phase readout
saveNCT07453095: Study With Glofitamab in Patients With MCL and Inadequate Response or Relapse Following CAR T-cell Therapy
NOT_YET_RECRUITINGupdated 2mo ago
community read0 votes
Sponsor: Fondazione Italiana Linfomi - ETS. Phase: PHASE2. Conditions: Mantle Cell Lymphoma
view source ↗
comments(0)
5-min edit window · permanent after that